Osaic Holdings
PACB icon

Osaic Holdings’s Pacific Biosciences PACB Stock Holding History

Osaic Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed -$6K – 7093
2021
Q1 		$6K Hold
10
– – ﹤0.01% 6082
2020
Q4 		$5K Buy
+10
New +$170 ﹤0.01% 5786

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's PACB Position: Q2 2026 in Review

Osaic Holdings increased its Pacific Biosciences (PACB) stake by 308% in Q2 2026, buying an estimated $181K and bringing the position to 164,522 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

Osaic Holdings first reported a position in PACB in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.85M in Q1 2022. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Osaic Holdings held 164,522 shares of Pacific Biosciences worth $276K as of Q2 2026.
  • Osaic Holdings bought 124,231 Pacific Biosciences shares in Q2 2026, an estimated $181K.
  • Pacific Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4167 holding.
  • Osaic Holdings first reported a position in Pacific Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Pacific Biosciences position peaked at $1.85M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.